enGene Therapeutics Inc. (ENGN): SC 13D/A filed Oct 18, 2024

Form type

SC 13D/A

Filing date

Oct 18, 2024

Accession number

0001193125-24-239641

Filer

enGene Therapeutics Inc. (CIK 1980845)